On March 10, 2022 Applied DNA Sciences, Inc. (NASDAQ: APDN), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing and nucleic acid-based technologies, reported that Chief Executive Officer Dr. James A. Hayward will host a virtual fireside chat with the Company’s covering analyst, Managing Director and Senior Research Analyst Jonathan Aschoff, on Monday, March 14, 2022, at the 34th Annual ROTH Investor Conference (Press release, Applied DNA Sciences, MAR 10, 2022, View Source;id=225876&p=2222207&I=1206939-c7Z3G6f3m8 [SID1234609917]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. Hayward, Beth Jantzen, chief financial officer, and Clay Shorrock, executive director of business development, will also host scheduled virtual one-on-one meetings with investors during the event.

To request a one-on-one meeting with Applied DNA, please email [email protected] or contact your Roth sales representative.

34th Annual Roth Investor Conference
Date: Monday, March 14, 2022
Time: 12:00 p.m. ET (9:00 a.m. ET)
Webcast: View Source

The fireside chat will be available for viewing and replay on the Investor Relations section of the Applied DNA website at www.adnas.com.